To the Editor:
The clinically important article by Antons et al.
1
places great weight on use of the creatinine kinase test in their algorithm (Figure 2). I have been interested in whether there is any alternative testing that might be more clinically reliable.2
Have the authors any experience with alternative blood testing in light of their described limits in creatinine kinase testing?References
- Clinical perspectives of statin-induced rhabdomyolysis.Am J Med. 2006; 119: 400-409
- Statin-associated myopathy with normal creatinine kinase levels.Ann Intern Med. 2003; 138 (1007): 12
Article Info
Identification
Copyright
© 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
